IP Library Granted Patent US 10,870,690
Granted Patent B2
US 10,870,690 · App. 15/609,370 · Granted Dec 22, 2020

Protein therapeutant and method for treating cancer

Inventor: Yihong Zhou (Irvine, CA)
C07K14/78A61K38/00C12N2740/15043
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,870,690
App. No.
15/609,370
Granted
Dec 22, 2020
Kind
B2
Abstract

The present invention relates to compositions for treating cancer by having one or more activities of inhibiting cancer growth, inhibiting cancer cell invasion, and inhibiting cancer recurrence.

Claims (9)

1. A method for treating cancer in a subject, comprising administering to the subject a therapeutically effective amount of a composition comprising an isolated polypeptide comprising an amino acid sequence selected from the group consisting of: a) SEQ ID NO:14; b) SEQ ID NO: 1; and c) SEQ ID NO: 2, wherein the cancer is a glioma.

2. The method of claim 1 , wherein the method results in at least one activity selected from the group consisting of inhibition of cancer cell invasion, inhibition of cancer cell growth and inhibiting cancer cell recurrence.

3. The method of claim 1 , wherein the tumor of the subject is characterized as-having activation of epidermal growth factor receptor (EGFR).

4. The method of claim 1 , wherein the cancer is selected from the group consisting of a low grade glioma, a medium grade glioma, a high grade glioma, and human glioblastoma multiforme.

5. The method of claim 1 , wherein the cancer is a glioblastoma multiforme.

6. The method of claim 1 , wherein the therapeutically effective amount of the composition is administered to a subject by intra-tumoral injection.

7. The method of claim 1 , wherein the tumor of the subject is characterized as having activation of NOTCH.

8. The method of claim 1 , wherein the tumor of the subject is characterized as having activation of AKT.

9. The method of claim 1 , wherein the tumor of the subject is characterized as having activation of an extracellular matrix metallopeptidase.

Continuity (4)
Continuation In Part 14771983
Provisional Application 62375196 · Aug 15, 2016
Provisional Application 61807445 · Apr 2, 2013
Related Publication 20170267747A1 · Sep 21, 2017